Back to Search
DAWN HOFFMANN, PHARMD
PHARMD
Pharmacist
NPI: 1346595436Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
20 056800(NY)
Research & Publications (20)
Immune-mediated anti-neoplastic effect of intratumoral RSV envelope glycoprotein expression is related to apoptotic death of tumor cells but not to the size of syncytia.
PMID 18350621·World J Gastroenterol·2008
7-preclinical
Evaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanoma.
PMID 17960177·J Invest Dermatol·2008
7-preclinical
Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors.
PMID 17912460·Int J Mol Med·2007
7-preclinical
Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
PMID 17640083·J Gene Med·2007
7-preclinical
Intratumoral expression of respiratory syncytial virus fusion protein in combination with cytokines encoded by adenoviral vectors as in situ tumor vaccine for colorectal cancer.
PMID 17620425·Mol Cancer Ther·2007
7-preclinical
In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines.
PMID 17589921·World J Gastroenterol·2007
7-preclinical
Local and distant immune-mediated control of colon cancer growth with fusogenic membrane glycoproteins in combination with viral oncolysis.
PMID 17518612·Hum Gene Ther·2007
7-preclinical
Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment.
PMID 17479104·Cancer Gene Ther·2007
8-other
Development of a method for fast analysis of phenolic molecular markers in biomass burning particles using high performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometry.
PMID 17257609·J Chromatogr A·2007
8-other
Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma.
PMID 17184155·Hum Gene Ther·2007
4-observational
Mutagenesis of hydrogenase accessory genes of Synechocystis sp. PCC 6803. Additional homologues of hypA and hypB are not active in hydrogenase maturation.
PMID 16972939·FEBS J·2006
8-other
Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy.
PMID 16928822·Mol Cancer Ther·2006
7-preclinical
Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
PMID 16887042·BMC Biotechnol·2006
7-preclinical
Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer.
PMID 16791286·Gene Ther·2006
7-preclinical
2,4-Dichlorophenoxyacetic acid (2,4-D) utilization by Delftia acidovorans MC1 at alkaline pH and in the presence of dichlorprop is improved by introduction of the tfdK gene.
PMID 16715405·Biodegradation·2006
4-observational
Restriction of adenoviral replication to the transcriptional intersection of two different promoters for colorectal and pancreatic cancer treatment.
PMID 16505112·Mol Cancer Ther·2006
8-other
Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
PMID 15945123·J Gene Med·2005
8-other
In vitro synthesis of enzymatically active HIV-1 protease for rapid phenotypic resistance profiling.
PMID 15780808·J Clin Virol·2005
4-observational
Rapid enzymatic test for phenotypic HIV protease drug resistance.
PMID 12956428·Biol Chem·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10 YOUNG ST
TONAWANDA, NY 14150 - Phone
- (716) 692-1894
Quick Facts
- NPI
- 1346595436
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile